Leesburg, Virginia – K2M Group Holdings Inc. officials announced the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the NILE Alternative Fixation Spinal System, the Company’s latest offering for addressing the most complex spinal deformity cases. K2M

Related posts:

  1. K2M Announces Enhanced Complex Spine Portfolio With Addition of Its Innovative NILE(TM) Alternative Fixation Spinal System
  2. K2M receives FDA 510(k) clearance for the next generation of its innovative complex spine MESA(R) technology
  3. K2M Continues Momentum with Complex Spine & Minimally Invasive Line Extensions & Regulatory Clearances
Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone